[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341488-105":59,"doc-detail-341488-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-suppressor-frmd3-controls-mammary-epithelial-cell-fate-determination-via-notch-signaling-pathway-research-paper","Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway - Research paper","","Luminal-to-basal transition in mammary epithelial cells reflects changing lineage plasticity, yet the controlling mechanism is unclear. The study reports that Frmd3 deficiency suppresses mammary gland lineage development while inducing stemness in mammary epithelial cells, promoting triple-negative breast cancer. In PyMT mice, Frmd3 loss drives a luminal-to-basal phenotype, and single-cell transcriptomics implicates inhibited Notch signaling. Mechanistically, FRMD3 promotes Disheveled-2 degradation via USP9x disruption and blocks key FRMD3–Disheveled-2 interactions, impairing Notch-dependent lineage plasticity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-suppressor-frmd3-controls-mammary-epithelial-cell-fate-determination-via-notch-signaling-pathway-research-paper/341488/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-suppressor-frmd3-controls-mammary-epithelial-cell-fate-determination-via-notch-signaling-pathway-research-paper/341488.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does Frmd3 deficiency affect mammary epithelial cells and breast cancer development?","Question",{"text":112,"@type":113},"Loss of Frmd3 inhibits mammary gland lineage development and induces stemness in mammary epithelial cells, which can lead to triple-negative breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What evidence links Frmd3 to Notch signaling?",{"text":117,"@type":113},"Single-cell RNA sequencing indicates that knockout of Frmd3 inhibits the Notch signaling pathway.",{"name":119,"@type":110,"acceptedAnswer":120},"By what mechanism does FRMD3 regulate Notch signaling and lineage plasticity?",{"text":121,"@type":113},"FRMD3 promotes degradation of Disheveled-2 by disrupting interaction with USP9x, and it also interrupts Disheveled-2 interactions with CK1, FOXK1/2, and NICD while reducing Disheveled-2 phosphorylation and nuclear localization, thereby impairing Notch-dependent luminal lineage plasticity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341488,1790192558,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","MOLECULAR BIOLOGY  \nTumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway  \nJi Ma1†, Yuqing Gong1†, Xiaoran Sun1,2†, Cheng Liu1, Xueying Li1, Yi Sun1, Decao Yang1, Junming He1, Mengyuan Wang1, Juan Du1, Jing Zhang1, Weizhi Xu1, Tianzhuo Wang1, Xiaochun Chi1, Yan Tang1, Jiagui Song1, Yunling Wang3, Fei Ma4*, Ceshi Chen5*,  \nHongquan Zhang1*, Jun Zhan1*  \nThe luminal-to-basal transition in mammary epithelial cells (MECs) is accompanied by changes in epithelial cell lineage plasticity; however, the underlying mechanism remains elusive. Here, we report that deficiency of Frmd3 inhibits mammary gland lineage development and induces stemness of MECs, subsequently leading to the occurrence of triple-negative breast cancer. Loss of Frmd3 in PyMT mice results in a luminal-to-basal transition phenotype. Single-cell RNA sequencing of MECs indicated that knockout ofFrmd3 inhibits the Notch signaling pathway. Mechanistically, FERM domain-containing protein 3 (FRMD3) promotes the degradation of Disheveled-2 by disrupting its interaction with deubiquitinase USP9x. FRMD3 also interrupts the interaction of Disheveled-2 with CK1, FOXK1/2, and NICD and decreases Disheveled-2 phosphorylation and nuclear localization, thereby impairing Notch-dependent luminal epithelial lineage plasticity in MECs. A low level of FRMD3 predicts poor outcomes for breast cancer patients. Together, we demonstrated that FRMD3 is a tumor suppressor that functions as an endogenous activator of the Notch signaling pathway, facilitating the basal-to-luminal transformation in MECs.  \ncopyright © 2024 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nTriple-negative breast cancer (TNBC) constitutes approximately 15 to 20% of breast cancers and is an aggressive subtype with a poor overall prognosis characterized by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (1). The basal-like subtype ofTNBC is the most common and is characterized by a high proliferation rate, basal epithelial markers, and low expression of luminal genes (2, 3). Claudinlow tumors are characterized by low to absent expression of luminal differentiation markers with marked enrichment of epithelial-tomesenchymal (EMT) transition markers and cancer stem cell (CSC)– like features. TNBC is the most difficult subtype of breast cancer to treat because of its aggressive clinical behavior and lack of therapeutic targets (4).  \nCSCs, also known as tumor-initiating cells, a subpopulation with high tumor initiation and repopulation abilities, have extensive selfrenewal potential, enabling them to recreate the heterogeneity of the original tumor by asymmetric division (5). Breast CSCs (bCSCs) can arise from transformed normal stem cells via the acquisition of genetic mutations; normal non-stem epithelial cells in which self-renewal is acquired by oncogenic events and transformation; or differentiated  \n1Program for cancer and cell Biology, department of human Anatomy, histology, and embryology, School of Basic Medical Sciences, and Peking University international cancer institute, State Key laboratory of Molecular Oncology, Peking University health Science center, Beijing 100191, china. 2department of Pathology, Peking University health Science center, Beijing 100191, china. 3institute of cardiovascular Research, Peking University health Science center, Beijing 100191, china. 4national cancer center, State Key laboratory of Molecular Oncology, cancer hospital, chinese Academy of Medical Sciences and Peking Union Medical college, Beijing, china. 5Key laboratory of Animal Models and human disease Mechanisms of the chinese Academy of Sciences and Yunnan Province, Kunming institute of Zoolog","cbCaitnqQ7j7WJ7D","https://ap.wps.com/l/cbCaitnqQ7j7WJ7D","pdf",15748641,18,"English","# Introduction\n## Triple-negative breast cancer overview\n## Breast cancer subtypes and cellular features\n## Cancer stem cells and cellular plasticity\n## Mammary gland and mammary stem cell hierarchy","[{\"question\":\"How does Frmd3 deficiency affect mammary epithelial cells and breast cancer development?\",\"answer\":\"Loss of Frmd3 inhibits mammary gland lineage development and induces stemness in mammary epithelial cells, which can lead to triple-negative breast cancer.\"},{\"question\":\"What evidence links Frmd3 to Notch signaling?\",\"answer\":\"Single-cell RNA sequencing indicates that knockout of Frmd3 inhibits the Notch signaling pathway.\"},{\"question\":\"By what mechanism does FRMD3 regulate Notch signaling and lineage plasticity?\",\"answer\":\"FRMD3 promotes degradation of Disheveled-2 by disrupting interaction with USP9x, and it also interrupts Disheveled-2 interactions with CK1, FOXK1/2, and NICD while reducing Disheveled-2 phosphorylation and nuclear localization, thereby impairing Notch-dependent luminal lineage plasticity.\"}]","Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway - Research paper | PDF",1790042115,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce59962192ee6392456eb2ca33ace4e2.webp",983,1250,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f959a0abdf8ea0579c9bf73bde1824b1.webp",982,1249,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fcc0cb692747a1918a8fdbc9e36ba6c.webp",981,1248,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae07c3ec69360ecac180342d1d5f0ce7.webp",980,1247]